BridgeBio · 7 hours ago
Business Development and Operations Intern
San Francisco, California, United States
Internship
Onsite
Intern
$30/hr - $30/hrBridgeBio is a company focused on pioneering advancements in biopharma, particularly in rare diseases. They are seeking a Business Development and Operations Intern who will take ownership of projects, contribute insights, and gain exposure to senior leaders across various functions while emphasizing education and professional development.
BiotechnologyHealth CareLife ScienceMedicalPharmaceutical
Responsibilities
Be ready to absorb information at a rapid pace
Given the brief nature of this role, emphasis will be placed on rapidly getting interns up to speed to encourage meaningful experience
With the unique nature of industry knowledge, interns will be expected to learn effectively through both direction and experience in a fast-paced environment
Formulate and communicate novel ideas
Interns will provide valuable insights and direction in their time with the company, employing their research and unique skill set to offer novel perspectives
Research conclusions will be presented meaningfully and effectively to senior leadership
Remain accountable and maintain an “ownership mindset” over projects
Interns will be given a variety of projects and will be held to a high standard in their execution of them
They will be expected to perform these tasks in a timely manner and will remain accountable to the leaders to which they report
Qualification
Required
A highly motivated, intellectually curious, and ambitious incoming university junior, university senior (preference), or Master's student with an interest in biopharma and finding ever better ways to serve patients
Comfortable learning quickly in ambiguous environments
Asking thoughtful questions
Taking ownership of work that matters
Excited by responsibility, exposure to senior leaders, and the opportunity to contribute meaningfully rather than observe from the sidelines
Experience: Professional experience in a high-intensity, fast-paced working environment
Entrepreneurial Mindset: A track record of experimenting with high-risk, high-reward initiatives
Cultural Fit: Energetic, resourceful, and scrappy, with a 'hustle harder' mindset
Be ready to absorb information at a rapid pace
Emphasis will be placed on rapidly getting interns up to speed to encourage meaningful experience
Interns will be expected to learn effectively through both direction and experience in a fast-paced environment
Formulate and communicate novel ideas
Interns will provide valuable insights and direction in their time with the company, employing their research and unique skill set to offer novel perspectives
Research conclusions will be presented meaningfully and effectively to senior leadership
Remain accountable and maintain an 'ownership mindset' over projects
Interns will be given a variety of projects and will be held to a high standard in their execution of them
They will be expected to perform these tasks in a timely manner and will remain accountable to the leaders to which they report
Patient Champions, who put patients first and uphold strict ethical standards
Entrepreneurial Operators, who drive toward practical solutions and have an ownership mindset
Truth Seekers, who are detailed, rational, and humble problem solvers
Individuals Who Inspire Excellence in themselves and those around them
High-Quality Executors, who execute against goals and milestones with quality, precision, and speed
Preferred
Rising 3rd or 4th year undergraduate actively pursuing a B.A. or B.S. in a life science or engineering related concentration, or Master's student pursuing a life science or engineering related concentration
Exceptional academic track record and GPA
Proven scientific acumen and an analytical mindset
Advanced written and verbal communication skills
Benefits
Base pay
An annual performance bonus
Company equity
Generous health benefits
Company
BridgeBio
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.
Founded in 2015
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$4.9BKey Investors
Blue OwlQatar Investment AuthorityKohlberg Kravis Roberts
2026-01-16Post Ipo Debt· $550M
2025-02-25Post Ipo Debt· $500M
2024-03-04Post Ipo Equity· $250M
Leadership Team
Justin To
CEO, Skeletal Dysplasias (QED Therapeutics)
Neil Kumar
CEO and Founder
Recent News
BioWorld Financial Watch
2026-01-17
Company data provided by crunchbase